These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 39271999

  • 1. Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli.
    Golpasand T, Keshvari M, Behzadi P.
    BMC Microbiol; 2024 Sep 14; 24(1):344. PubMed ID: 39271999
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.
    Sheikhi R, Amini ME, Alidoust L, Atrkar Roushan Z, Nikokar I.
    J Infect Dev Ctries; 2024 May 30; 18(5):761-769. PubMed ID: 38865401
    [Abstract] [Full Text] [Related]

  • 3. Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli.
    Luna-Pineda VM, Reyes-Grajeda JP, Cruz-Córdova A, Saldaña-Ahuactzi Z, Ochoa SA, Maldonado-Bernal C, Cázares-Domínguez V, Moreno-Fierros L, Arellano-Galindo J, Hernández-Castro R, Xicohtencatl-Cortes J.
    Front Cell Infect Microbiol; 2016 May 30; 6():135. PubMed ID: 27843814
    [Abstract] [Full Text] [Related]

  • 4. Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic Escherichia coli isolates in relation to the antimicrobial resistance.
    Kadry AA, Al-Kashef NM, El-Ganiny AM.
    Afr Health Sci; 2020 Mar 30; 20(1):238-247. PubMed ID: 33402912
    [Abstract] [Full Text] [Related]

  • 5. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H, Esmaeeli E, Ghafourian S, Maleki A, Sadeghifard N.
    Infect Disord Drug Targets; 2019 Mar 30; 19(3):322-326. PubMed ID: 30421685
    [Abstract] [Full Text] [Related]

  • 6. Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients.
    Ghosh A, Mukherjee M.
    Folia Microbiol (Praha); 2019 Jul 30; 64(4):587-600. PubMed ID: 30835050
    [Abstract] [Full Text] [Related]

  • 7. Snapshot of Phylogenetic Groups, Virulence, and Resistance Markers in Escherichia coli Uropathogenic Strains Isolated from Outpatients with Urinary Tract Infections in Bucharest, Romania.
    Cristea VC, Gheorghe I, Czobor Barbu I, Popa LI, Ispas B, Grigore GA, Bucatariu I, Popa GL, Angelescu MC, Velican A, Marutescu L, Popa M, Chifiriuc MC, Popa IM.
    Biomed Res Int; 2019 Jul 30; 2019():5712371. PubMed ID: 31236408
    [Abstract] [Full Text] [Related]

  • 8. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?
    Scharf B, Schmidt TJ, Rabbani S, Stork C, Dobrindt U, Sendker J, Ernst B, Hensel A.
    J Ethnopharmacol; 2020 Jul 15; 257():112889. PubMed ID: 32311481
    [Abstract] [Full Text] [Related]

  • 9. Type 1 fimbrial phase variation in multidrug-resistant asymptomatic uropathogenic Escherichia coli clinical isolates upon adherence to HTB-4 cells.
    Ghosh A, Mukherjee M.
    Folia Microbiol (Praha); 2024 Dec 15; 69(6):1185-1204. PubMed ID: 38568394
    [Abstract] [Full Text] [Related]

  • 10. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs).
    Behzadi P.
    Folia Microbiol (Praha); 2020 Feb 15; 65(1):45-65. PubMed ID: 31165977
    [Abstract] [Full Text] [Related]

  • 11. Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic Escherichia coli Isolates from Patients with Urinary Tract Infections in a Tertiary Teaching Hospital in Iran.
    Neamati F, Khorshidi A, Moniri R, Hosseini Tafreshi SA.
    Microb Drug Resist; 2020 Jan 15; 26(1):60-70. PubMed ID: 31526226
    [Abstract] [Full Text] [Related]

  • 12. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
    Rafsanjany N, Senker J, Brandt S, Dobrindt U, Hensel A.
    J Agric Food Chem; 2015 Oct 14; 63(40):8804-18. PubMed ID: 26330108
    [Abstract] [Full Text] [Related]

  • 13. Uropathogenic Escherichia coli strains harboring tosA gene were associated to high virulence genes and a multidrug-resistant profile.
    Xicohtencatl-Cortes J, Cruz-Córdova A, Cázares-Domínguez V, Escalona-Venegas G, Zavala-Vega S, Arellano-Galindo J, Romo-Castillo M, Hernández-Castro R, Ochoa SA, Luna-Pineda VM.
    Microb Pathog; 2019 Sep 14; 134():103593. PubMed ID: 31195111
    [Abstract] [Full Text] [Related]

  • 14. Virulence Genotyping and Multidrug Resistance Pattern of Escherichia coli Isolated From Community-Acquired and Hospital-Acquired Urinary Tract Infections.
    Radera S, Srivastava S, Agarwal J.
    Cureus; 2022 Sep 14; 14(9):e29404. PubMed ID: 36304345
    [Abstract] [Full Text] [Related]

  • 15. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.
    Spaulding CN, Klein RD, Ruer S, Kau AL, Schreiber HL, Cusumano ZT, Dodson KW, Pinkner JS, Fremont DH, Janetka JW, Remaut H, Gordon JI, Hultgren SJ.
    Nature; 2017 Jun 22; 546(7659):528-532. PubMed ID: 28614296
    [Abstract] [Full Text] [Related]

  • 16. Genetic relatedness of the Escherichia coli fecal population and strains causing urinary tract infection in the same host.
    Bahadori M, Motamedifar M, Derakhshandeh A, Firouzi R, Motamedi Boroojeni A, Alinejad M, Naziri Z.
    Microbiologyopen; 2019 Jun 22; 8(6):e00759. PubMed ID: 30358940
    [Abstract] [Full Text] [Related]

  • 17. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
    Paniagua-Contreras GL, Monroy-Pérez E, Bautista A, Reyes R, Vicente A, Vaca-Paniagua F, Díaz CE, Martínez S, Domínguez P, García LR, Uribe-García A, Vaca S.
    Pathog Glob Health; 2018 Dec 22; 112(8):415-420. PubMed ID: 30433859
    [Abstract] [Full Text] [Related]

  • 18. MOLECULAR CHARACTERIZATION OF VIRULENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF UROPATHOGENIC ESCHERICHIA COLI FROM PATIENTS IN A TERTIARY HOSPITAL, SOUTHERN THAILAND.
    Themphachanal M, Kongpheng S, Rattanachuay P, Khianngam S, Singkhamanan K, Sukhumungoon P.
    Southeast Asian J Trop Med Public Health; 2015 Nov 22; 46(6):1021-30. PubMed ID: 26867360
    [Abstract] [Full Text] [Related]

  • 19. Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC.
    Gupta S, Kumar P, Rathi B, Verma V, Dhanda RS, Devi P, Yadav M.
    Sci Rep; 2021 Sep 07; 11(1):17801. PubMed ID: 34493749
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.